Working… Menu
Trial record 1 of 1 for:    qolixane
Previous Study | Return to List | Next Study

Observational Study on Quality of Life of Patients Receiving Nab-paclitaxel/Gemcitabine First Line Therapy, Including a Translational Program (QoliXane)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02691052
Recruitment Status : Completed
First Posted : February 25, 2016
Last Update Posted : April 21, 2020
Trium Analysis Online GmbH
mca Berlin
Information provided by (Responsible Party):
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest